Jan E. Carlsen

5.7k total citations · 3 hit papers
47 papers, 3.9k citations indexed

About

Jan E. Carlsen is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Jan E. Carlsen has authored 47 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Jan E. Carlsen's work include Blood Pressure and Hypertension Studies (10 papers), Heart Failure Treatment and Management (10 papers) and Cardiac electrophysiology and arrhythmias (10 papers). Jan E. Carlsen is often cited by papers focused on Blood Pressure and Hypertension Studies (10 papers), Heart Failure Treatment and Management (10 papers) and Cardiac electrophysiology and arrhythmias (10 papers). Jan E. Carlsen collaborates with scholars based in Denmark, United Kingdom and United States. Jan E. Carlsen's co-authors include Lars Køber, Christian Torp‐Pedersen, Jørgen Videbæk, David Cole, N Pauly, K Lyngborg, Laurent Auclert, Stig Persson, Etienne Aliot and A. John Camm and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Jan E. Carlsen

46 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction

1995 1.3k citations Lars Køber, Christian Torp‐Pedersen et al. New England Journal of Medicine profile →
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction

1999 738 citations Christian Torp‐Pedersen, Mogens Møller et al. New England Journal of Medicine profile →
Increased Mortality after Dronedarone Therapy for Severe Heart Failure

2008 584 citations Lars Køber, Christian Torp‐Pedersen et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan E. Carlsen Denmark	22	3.3k	405	375	311	280	47	3.9k
Robert DiBianco United States	21	2.8k 0.8×	535 1.3×	167 0.4×	454 1.5×	165 0.6×	53	3.3k
Mary Ann Lukas United States	26	3.0k 0.9×	325 0.8×	615 1.6×	450 1.4×	127 0.5×	59	3.7k
Kalina Kawecka−Jaszcz Poland	30	2.7k 0.8×	264 0.7×	565 1.5×	546 1.8×	274 1.0×	244	3.7k
H. Pouleur Belgium	34	3.3k 1.0×	423 1.0×	283 0.8×	491 1.6×	703 2.5×	150	3.9k
Milton L. Pressler United States	21	2.0k 0.6×	638 1.6×	224 0.6×	484 1.6×	140 0.5×	39	2.8k
W. Bruce Dunkman United States	20	5.5k 1.7×	338 0.8×	320 0.9×	779 2.5×	323 1.2×	27	6.0k
Raphael F. Smith United States	24	3.1k 1.0×	256 0.6×	192 0.5×	454 1.5×	281 1.0×	42	3.6k
Jean‐Pierre Boissel France	22	1.7k 0.5×	249 0.6×	458 1.2×	513 1.6×	91 0.3×	53	2.9k
Gordon W. Moe Canada	34	2.6k 0.8×	606 1.5×	208 0.6×	350 1.1×	211 0.8×	89	3.4k
Manuel Worcel France	26	1.7k 0.5×	650 1.6×	556 1.5×	271 0.9×	90 0.3×	86	3.1k

Countries citing papers authored by Jan E. Carlsen

Since Specialization

Citations

This map shows the geographic impact of Jan E. Carlsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan E. Carlsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan E. Carlsen more than expected).

Fields of papers citing papers by Jan E. Carlsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan E. Carlsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan E. Carlsen. The network helps show where Jan E. Carlsen may publish in the future.

Co-authorship network of co-authors of Jan E. Carlsen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan E. Carlsen. A scholar is included among the top collaborators of Jan E. Carlsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan E. Carlsen. Jan E. Carlsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lewis, Roger, Derek C. Angus, Pierre‐François Laterre, et al.. (2018). Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock—Adaptive Clinical Trial. Annals of the American Thoracic Society. 15(2). 250–257. 21 indexed citations

Torp‐Pedersen, Christian, Lars Køber, Jan E. Carlsen, et al.. (2008). A Randomised Trial of a Pre-Synaptic Stimulator of DA2-Dopaminergic and α2-Adrenergic Receptors on Morbidity and Mortality in Patients with Heart Failure. European Journal of Heart Failure. 10(1). 89–95. 32 indexed citations

Køber, Lars, Christian Torp‐Pedersen, John J.V. McMurray, et al.. (2008). Increased Mortality after Dronedarone Therapy for Severe Heart Failure. New England Journal of Medicine. 358(25). 2678–2687. 584 indexed citations breakdown →

Buch, Pernille, Søren Rasmussen, Steen Z. Abildstrøm, et al.. (2004). The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years. European Heart Journal. 26(2). 145–152. 34 indexed citations

Torp‐Pedersen, Christian, Lars Køber, Stephen G. Ball, et al.. (2002). The Incomplete Bucindolol Evaluation in Acute Myocardial Infarction Trial (BEAT). European Journal of Heart Failure. 4(4). 495–499. 20 indexed citations

Køber, Lars, Poul Erik Bloch Thomsen, Mogens Møller, et al.. (2000). Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. The Lancet. 356(9247). 2052–2058. 235 indexed citations

Torp‐Pedersen, Christian, Mogens Møller, Lars Køber, et al.. (1999). Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction. New England Journal of Medicine. 341(12). 857–865. 738 indexed citations breakdown →

Nørgaard, Kirsten, Lars Køber, & Jan E. Carlsen. (1997). The effect of metformin on blood pressure and metabolism in nondiabetic hypertensive patients. Journal of Internal Medicine. 242(5). 407–412. 38 indexed citations

Køber, Lars, Christian Torp‐Pedersen, Jan E. Carlsen, et al.. (1995). A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction. New England Journal of Medicine. 333(25). 1670–1676. 1254 indexed citations breakdown →

10.

Tranum-Jensen, J, et al.. (1994). Membrane topology of insulin receptors reconstituted into lipid vesicles. The Journal of Membrane Biology. 140(3). 215–23. 17 indexed citations

11.

Carlsen, Jan E., et al.. (1991). Comparison of Efficacy and Tolerability of Spirapril and Nitrendipine in Arterial Hypertension. Clinical Drug Investigation. 3(3). 172–177. 3 indexed citations

12.

Carlsen, Jan E., Lars Køber, Christian Torp‐Pedersen, & Peter Johansen. (1990). Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.. BMJ. 300(6730). 975–978. 186 indexed citations

13.

Carlsen, Jan E.. (1990). Clinical trials of potassium channel openers. European Journal of Pharmacology. 183(1). 70–71. 1 indexed citations

14.

Carlsen, Jan E., et al.. (1989). Efficacy and Safety of Cilazapril in Hypertensive Patients with Moderate to Severe Renal Impairment. The American Journal of Medicine. 87(6). 79S–82S. 6 indexed citations

15.

Steensgaard-Hansen, Frank & Jan E. Carlsen. (1988). Effects of Long Term Treatment with Pinacidil and Nifedipine on Left Ventricular Anatomy and Function in Patients with Mild to Moderate Systemic Hypertension. Drugs. 36(Supplement 7). 70–76. 9 indexed citations

16.

Carlsen, Jan E., et al.. (1988). Rat hepatic microsomal cytochrome b5. A simple large-scale purification procedure and antibody production by antigen-containing liposomes. Biochemical Journal. 256(3). 1051–1054. 5 indexed citations

17.

Kardel, Troels, T Hilden, Jan E. Carlsen, & J. Trap‐Jensen. (1981). N-N-Cyano--4-pyridyl-N'-1,2,2-trimethyl-propylguanidine, a New Vasodilating Agent. Journal of Cardiovascular Pharmacology. 3(5). 1002–1007. 39 indexed citations

18.

Carlsen, Jan E., et al.. (1981). Immediate central and peripheral haemodynamic effects of a new vasodilating agent Pinacidil (P1134) in hypertensive man. Clinical Physiology. 1(4). 375–384. 46 indexed citations

19.

Svendsen, Tage Lysbo, Jan E. Carlsen, O. J. Hartling, Allan McNair, & J. Trap‐Jensen. (1980). A Comparison of the Acute Haemodynamic Effects of Propranolol and Pindolol at Rest and during Supine Exercise in Man. Clinical Science. 59(s6). 465s–468s. 32 indexed citations

20.

Carlsen, Jan E., et al.. (1977). Common duct stones in patients with acute cholecystitis.. PubMed. 143(1). 47–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact